Report cover image

Europe Synthetic Biology Market Size, Share & Trends Analysis Report By Application, By End-use, By Product, By Technology (PCR Technology, NGS Technology, Genome Editing Technology, Bioprocessing Technology and Others), By Country and Growth Forecast, 20

Publisher Knowledge Based Value (KBV) Research
Published Jan 31, 2024
Length 136 Pages
SKU # KBV18593060

Description

Europe Synthetic Biology Market Size, Share & Trends Analysis Report By Application, By End-use, By Product, By Technology (PCR Technology, NGS Technology, Genome Editing Technology, Bioprocessing Technology and Others), By Country and Growth Forecast, 2023 - 2030


The Europe Synthetic Biology Market would witness market growth of 18.5% CAGR during the forecast period (2023-2030).

Synthetic biology, an interdisciplinary field combining principles from biology, engineering, and computer science, has emerged as a transformative force in biotechnology. The synthetic biology market is characterized by designing and constructing new biological entities or redesigning existing biological systems for practical applications. This innovative approach leverages the tools of genetic engineering, bioinformatics, and systems biology to engineer biological components, organisms, and systems with novel functionalities.

In addition, academic and research institutions are crucial in facilitating the implementation of synthetic biology. Researchers and scientists in biology, bioengineering, and related fields utilize synthetic biology techniques to explore fundamental biological principles, create novel biological systems, and contribute to the expanding body of knowledge in the field. Likewise, biotechnology and pharmaceutical companies embrace synthetic biology for drug discovery, biomanufacturing, and developing advanced therapies. Engineered microorganisms produce biotherapeutics, enzymes, and valuable compounds, accelerating the pace of drug development and manufacturing processes.

Italy has a strong tradition in scientific research, and the biotechnology sector has been increasingly gaining attention. The country has numerous research institutions and universities engaged in cutting-edge biotechnological research, providing a fertile ground for the growth of synthetic biology. Thus, growing R&D investments and biotechnology industry in Europe will boost the demand for synthetic biology in the region.

The Germany market dominated the Europe Synthetic Biology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,806.7 million by 2030. The UK market is exhibiting a CAGR of 17.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 19.4% during (2023 - 2030).

Based on End-use, the market is segmented into Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Others. Based on Product, the market is segmented into Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, and Chassis Organism. Based on Technology, the market is segmented into PCR Technology, NGS Technology, Genome Editing Technology, Bioprocessing Technology and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Thermo Fisher Scientific, Inc.
  • Genscript Biotech Corporation
  • DNA TwoPointO Inc. (Atum)
  • Integrated DNA Technologies, Inc. (Danaher Corporation)
  • Eurofins Scientific SE
  • OriGene Technologies, Inc.
  • Twist Bioscience Corporation
  • Editas Medicine, Inc.
  • Agilent Technologies, Inc.
  • Merck KGaA
Europe Synthetic Biology Market Report Segmentation

By Application
  • Healthcare
  • Non-healthcare
By End-use
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Others
By Product
  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism
By Technology
  • PCR Technology
  • NGS Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

136 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Synthetic Biology Market, by Application
1.4.2 Europe Synthetic Biology Market, by End-use
1.4.3 Europe Synthetic Biology Market, by Product
1.4.4 Europe Synthetic Biology Market, by Technology
1.4.5 Europe Synthetic Biology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Synthetic Biology Market by Application
4.1 Europe Healthcare Market by Country
4.2 Europe Non-healthcare Market by Country
Chapter 5. Europe Synthetic Biology Market by End-use
5.1 Europe Biotechnology and Pharmaceutical Companies Market by Country
5.2 Europe Academic and Government Research Institutes Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Synthetic Biology Market by Product
6.1 Europe Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country
6.2 Europe Enzymes Market by Country
6.3 Europe Cloning Technologies Kits Market by Country
6.4 Europe Xeno-Nucleic Acids Market by Country
6.5 Europe Chassis Organism Market by Country
Chapter 7. Europe Synthetic Biology Market by Technology
7.1 Europe PCR Technology Market by Country
7.2 Europe NGS Technology Market by Country
7.3 Europe Genome Editing Technology Market by Country
7.4 Europe Bioprocessing Technology Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Synthetic Biology Market by Country
8.1 Germany Synthetic Biology Market
8.1.1 Germany Synthetic Biology Market by Application
8.1.2 Germany Synthetic Biology Market by End-use
8.1.3 Germany Synthetic Biology Market by Product
8.1.4 Germany Synthetic Biology Market by Technology
8.2 UK Synthetic Biology Market
8.2.1 UK Synthetic Biology Market by Application
8.2.2 UK Synthetic Biology Market by End-use
8.2.3 UK Synthetic Biology Market by Product
8.2.4 UK Synthetic Biology Market by Technology
8.3 France Synthetic Biology Market
8.3.1 France Synthetic Biology Market by Application
8.3.2 France Synthetic Biology Market by End-use
8.3.3 France Synthetic Biology Market by Product
8.3.4 France Synthetic Biology Market by Technology
8.4 Russia Synthetic Biology Market
8.4.1 Russia Synthetic Biology Market by Application
8.4.2 Russia Synthetic Biology Market by End-use
8.4.3 Russia Synthetic Biology Market by Product
8.4.4 Russia Synthetic Biology Market by Technology
8.5 Spain Synthetic Biology Market
8.5.1 Spain Synthetic Biology Market by Application
8.5.2 Spain Synthetic Biology Market by End-use
8.5.3 Spain Synthetic Biology Market by Product
8.5.4 Spain Synthetic Biology Market by Technology
8.6 Italy Synthetic Biology Market
8.6.1 Italy Synthetic Biology Market by Application
8.6.2 Italy Synthetic Biology Market by End-use
8.6.3 Italy Synthetic Biology Market by Product
8.6.4 Italy Synthetic Biology Market by Technology
8.7 Rest of Europe Synthetic Biology Market
8.7.1 Rest of Europe Synthetic Biology Market by Application
8.7.2 Rest of Europe Synthetic Biology Market by End-use
8.7.3 Rest of Europe Synthetic Biology Market by Product
8.7.4 Rest of Europe Synthetic Biology Market by Technology
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Genscript Biotech Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 DNA TwoPointO Inc. (Atum)
9.3.1 Company Overview
9.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Eurofins Scientific SE
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 SWOT Analysis
9.6 OriGene Technologies, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Twist Bioscience Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Editas Medicine, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expenses
9.8.4 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Merck KGaA
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us